|Day Low/High||10.85 / 10.90|
|52 Wk Low/High||6.10 / 10.78|
Updates Include CE Mark Approval for GentleTouch® Hair Removal System, FDA Clearance on PicoWay Resolve® for Acne Scars, Availability of UltraShape Power® and FDA Clearance of Profound® to Improve the Appearance of Cellulite
In Addition, the United States Patent and Trademark Office (USPTO) Has Issued a Notice of Allowance for US Patent Covering the Technology Used in Profound™.
New ultra-short 785nm wavelength is first-of-its-kind in the aesthetic market, enabling comprehensive tattoo removal with PicoWay
UltraShape Power provides a 20% increase in Acoustic Energy; Demonstrates 32% reduction in abdominal fat layer thickness
Industry-leading Physicians Present 11 Abstracts Highlighting Performance and Ease-of-Use of PicoWay, CO2RE, elos® and Profound Technologies
- Syneron Special Offering To Allergan Partner Privileges® Members on Select Syneron Aesthetic Products -
Debuts include the new CO2RE Intima for gynecological and genitourinary indications for vaginal and vulvar health, an additional ultra-short PicoWay laser wavelength for comprehensive tattoo removal and a SubQ Profound applicator for the stimulation of elastin, collagen, hyaluronic acid and the treatment of adipose tissue.
Resolve™ - Revolutionary fractional module for PicoWay with 2 wavelengths: 532nm and 1064nm for skin rejuvenation, pigmented lesions and toning